0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
ARTICLE |

USE OF ALPHA TOCOPHEROL IN THE TREATMENT OF NEUROMUSCULAR DISORDERS

ALBERT J. LUBIN, M.D.
Arch Intern Med (Chic). 1942;69(5):836-855. doi:10.1001/archinte.1942.00200170118009.
Text Size: A A A
Published online

On the basis of experimental paralyses produced in animals by Evans and Burr,1 Einarson and Ringsted2 and others, vitamin E and alpha tocopherol, an alcohol isolated from wheat germ oil having apparently all of the properties of the vitamin, have been rather widely advocated as therapeutic agents for a variety of diseases of the neuromuscular system, especially amyotrophic lateral sclerosis and progressive muscular dystrophy. The favorable clinical reports of Bicknell3 and Wechsler4 have been followed by those of Stone,5 Vilter, Aring and Spies,6 and Rosenberger7 and by a considerable body of literature distributed by various pharmaceutic companies and, indeed, by the lay press. However, the reports of others8 make it clear that the efficacy of the therapy is far from proved.

This report covers a group of 35 patients treated with large doses of synthetic alpha tocopherol, beginning May 1940. The purpose of the study was to

Topics

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

First Page Preview

View Large
First page PDF preview

First Page Preview

View Large
First page PDF preview

Figures

Tables

References

Correspondence

CME
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
Submit a Comment

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs
brightcove.createExperiences();